 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 April 1993 | Volume 118 Issue 7 | Pages 529-539
Purpose: To review the medications that influence glucose metabolism and to examine the mechanisms of these medications on glucose metabolism.
Data Sources: Data were obtained from a MEDLINE search back to 1966 and included animal and human studies published in the English language.
Study Selection: Approximately 80% of original publications were included after review by the authors. Case reports were included if they provided additional information.
Date Extraction: The original data from the literature were included on the basis of independent extraction by the authors.
Data Synthesis: Many common therapeutic agents influence glucose metabolism. Multiple mechanisms of action on glucose metabolism exist through pancreatic, hepatic, and peripheral effects. Based on circumstances at the time of use, a drug may cause both hyper- and hypoglycemia in a patient. The patient's previous pancreatic reserve, nutritional state, use of other medication, or exposure to alcohol may influence the direction of the plasma glucose alterations.
Conclusion: Hyperinsulinemia and insulin resistance form an intrinsic component of diabetes, hyperlipidemia, and atherosclerotic vascular disease (syndrome X). The induction of hyperinsulinemia and insulin resistance by medication may therefore counteract intended benefits. An extensive review of recent medication in patients with disorders of glucose tolerance and the avoidance of polypharmacy are recommended. It is prudent to monitor plasma glucose values when it is not possible to avoid prescription of medication with known effects on carbohydrate metabolism.
Author and Article Information
From the Louisville Veterans Affairs Medical Center and the University of Louisville, Louisville, Kentucky; the Fargo Veterans Affairs Medical Center and the University of North Dakota, Fargo, North Dakota.
REVIEW
Drug-induced Disorders of Glucose Tolerance
Requests for Reprints: Alan N. Peiris, MD, VAMC-151A, 800 Zorn Avenue, Louisville, Kentucky 40206.
Acknowledgments: The authors thank Nancy Fletcher for secretarial assistance, Paul Matuschka and the Pharmacy staff, and Lynn Thomason and the Medical library staff at the Louisville Veterans hospital for invaluable help during the preparation of this article, and Vasti Broadstone, MD, for comments.
This article has been cited by other articles:
|
|
 |
|
  K. Scott Baker, K. K. Ness, J. Steinberger, A. Carter, L. Francisco, L. J. Burns, C. Sklar, S. Forman, D. Weisdorf, J. G. Gurney, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study Blood, February 15, 2007; 109(4): 1765 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sam, R. S. Legro, P. A. Essah, T. Apridonidze, and A. Dunaif Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome PNAS, May 2, 2006; 103(18): 7030 - 7035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Y. Park-Wyllie, D. N. Juurlink, A. Kopp, B. R. Shah, T. A. Stukel, C. Stumpo, L. Dresser, D. E. Low, and M. M. Mamdani Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults N. Engl. J. Med., March 30, 2006; 354(13): 1352 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sam, R. S. Legro, R. Bentley-Lewis, and A. Dunaif Dyslipidemia and Metabolic Syndrome in the Sisters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4797 - 4802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Lee Altered Glucose Metabolism in HIV-infected Patients Treated With HAART Journal of Pharmacy Practice, February 1, 2004; 17(1): 80 - 86. [Abstract] [PDF]
|
|
|
|
 |
|
 J.-N. Wei, F.-C. Sung, C.-C. Lin, R.-S. Lin, C.-C. Chiang, and L.-M. Chuang National Surveillance for Type 2 Diabetes Mellitus in Taiwanese Children JAMA, September 10, 2003; 290(10): 1345 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Meslier, F. Gagnadoux, P. Giraud, C. Person, H. Ouksel, T. Urban, and J-L. Racineux Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Eur. Respir. J., July 1, 2003; 22(1): 156 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care, January 1, 2003; 26(90001): s5 - 20. [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Kroner Common Drug Pathways and Interactions Diabetes Spectr, October 1, 2002; 15(4): 249 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Newcomer, D. W. Haupt, R. Fucetola, A. K. Melson, J. A. Schweiger, B. P. Cooper, and G. Selke Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia Arch Gen Psychiatry, April 1, 2002; 59(4): 337 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Luna and M. N. Feinglos Drug-Induced Hyperglycemia JAMA, October 24, 2001; 286(16): 1945 - 1948. [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Henderson, E. Cagliero, C. Gray, R. A. Nasrallah, D. L. Hayden, D. A. Schoenfeld, and D. C. Goff Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study Am J Psychiatry, June 1, 2000; 157(6): 975 - 981. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Gerich Insulin Resistance Is Not Necessarily an Essential Component of Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2113 - 2115. [Full Text]
|
|
|
|
 |
|
 E. C. C. Lee, S. Walmsley, and I. G. Fantus New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review Can. Med. Assoc. J., July 1, 1999; 161(2): 161 - 164. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kiechl, J. Willeit, W. Poewe, G. Egger, F. Oberhollenzer, M. Muggeo, and E. Bonora Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ, October 26, 1996; 313(7064): 1040 - 1044. [Abstract] [Full Text]
|
|
Article
